Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoCellular Therapeutics Ltd (NYSE American:IMUC)

0.35
Delayed Data
As of Sep 22
 +0.0234 / +7.16%
Today’s Change
0.25
Today|||52-Week Range
4.96
-82.93%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.33
Today’s open0.33
Day’s range0.33 - 0.36
Volume1,375,150
Average volume (3 months)1,448,391
Market cap$5.2M
Dividend yield--
Data as of 7:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-31.50%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.18

Competitors

 Today’s
change
Today’s
% change
SGLBSigma Labs Inc+0.02+1.04%
YTENYield10 Bioscience I...+0.19+5.81%
BASIBioanalytical System...+0.04+2.33%
OPGNOpGen Inc+0.01+4.64%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 10, 2017
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$0.00
Annual profit (last year)-$22.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Secretary
Gary S. Titus
President, Chief Executive Officer &
Director
Anthony J. Gringeri
Corporate headquarters
Calabasas, California

Forecasts